Shares of Lloyds Banking Group plc (LON:LLOY – Get Free Report) have earned a consensus recommendation of “Hold” from the eight analysts that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and one has given a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is GBX 55.50 ($0.70).
A number of equities analysts have recently issued reports on the stock. Shore Capital reiterated a “hold” rating on shares of Lloyds Banking Group in a research note on Wednesday, October 23rd. Royal Bank of Canada reaffirmed a “sector perform” rating and set a GBX 60 ($0.76) target price on shares of Lloyds Banking Group in a research report on Thursday, October 24th. Berenberg Bank reissued a “hold” rating and issued a GBX 55 ($0.69) price target on shares of Lloyds Banking Group in a research report on Wednesday, August 21st. Finally, Citigroup reaffirmed a “neutral” rating on shares of Lloyds Banking Group in a research report on Thursday, October 24th.
Read Our Latest Research Report on LLOY
Lloyds Banking Group Price Performance
About Lloyds Banking Group
Lloyds Banking Group plc, together with its subsidiaries, provides a range of banking and financial services in the United Kingdom and internationally. It operates in three segments: Retail; Commercial Banking; and Insurance, Pensions and Investments. The Retail segment offers a range of financial service products, including current accounts, savings, mortgages, motor finance, unsecured loans, leasing solutions, and credit cards to personal customers.
Read More
- Five stocks we like better than Lloyds Banking Group
- Insider Trades May Not Tell You What You Think
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Invest in the Best Canadian Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Upcoming IPO Stock Lockup Period, Explained
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Lloyds Banking Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lloyds Banking Group and related companies with MarketBeat.com's FREE daily email newsletter.